Clinical Trials in Philadelphia

Showing 4861-4880 of 20,904 trials

Using Artificial Intelligence to Optimize Delivery of Weight Loss Treatment

NCT05231824

Project ReLearn is testing the efficacy and cost-effectiveness of an Artificial Intelligence system for optimizing weight loss coaching. Participants are randomized to a 1-year weekly gold standard behavioral weight loss remote (video) group treatment or the AI-optimized treatment, which is made up of a combination of remote group treatment, short video call and automated message. In the AI-optimized condition, the system monitors outcomes (via wireless scale, mobile phone app, and wristworn tracker) and, each week, assigns each participant the treatments they have responding to the best, within certain time constraints.

ObesityWeight Loss

Drexel University336 participantsStarted Mar 2022

Philadelphia, Pennsylvania, United States

TERMINATEDPhase 1/2< 1 mile

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

NCT06679582

This trial will evaluate whether luveltamab tazevibulin is well tolerated and active against a rare form of AML carrying a particular genetic abnormality called CBFA2T3::GLIS2 that arises in infants and children. To be treated in this trial children must have a leukemia which did not respond or recurred after prior treatment. Luveltamab tazevibulin is an antibody-drug conjugate, which brings tazevibulin, an anticancer drug, to a molecule called FOLR1, present on the surface of CBFA2T3::GLIS2 AML cells.

Acute Myeloid Leukemia (AML)

Sutro Biopharma, Inc.24 participantsStarted Dec 2024

Birmingham, Alabama, United States • Los Angeles, California, United States • Palo Alto, California, United States +33 more locations

Using Artificial Intelligence to Optimize Delivery of Weight Loss Treatment

Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML

Find Trials by Condition in Philadelphia

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

Real-time fMRI for Insular Cortex Brain State-triggered Experience Sampling

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Study of JK07 in Patients With Chronic Heart Failure

ERG Components in Schizophrenia and Bipolar Disorder Type I

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)

CCT-102 or Expectant Management in Delayed Pregnancy Loss

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

A Clinical Study on Acuris™ - Conometric Concept for Single Tooth Restoration